During the past decade, Cleveland Clinic Cancer Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 52 clinical trials were completed, i.e. on average, 288.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 24 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 57 trials, followed by "Gynecologic Oncology Group" with 18 trials sponsored, "National Cancer Institute (NCI)" with 14 trials sponsored, "Radiation Therapy Oncology Group" with 14 trials sponsored and "Eastern Cooperative Oncology Group" with 14 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 111 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "North Central Cancer Treatment Group" with 7 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Cancer Center" are "Breast Cancer" (21 trials), "Lymphoma" (15 trials), "Lung Cancer" (11 trials), "Ovarian Cancer" (11 trials) and "Primary Peritoneal Cavity Cancer" (10 trials). Many other conditions were trialed in "Cleveland Clinic Cancer Center" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Cancer Center" are "Drug" (128 trials), "Biological" (33 trials), "Radiation" (32 trials), "Other" (31 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "cisplatin" (19 trials), "paclitaxel" (17 trials), "cyclophosphamide" (14 trials) and "doxorubicin hydrochloride" (13 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Cancer Center" are 94 trials for "All" genders, 40 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Cleveland Clinic Cancer Center". undefined are not yet recruiting, 6 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 88 completed trials in Cleveland Clinic Cancer Center, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Cancer Center, 8 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".